mycsg.in
SAS
SASnR
Clinical Programming
CRFs
SDTM
ADaM
TFL
Tasks
Macros
QnA
Certification
Resources
Disclaimer
Contact Us
Sign Up
Login
This website uses cookies to personalize content and analyse traffic in order to offer you a better experience. By clicking "OK", or continuing using our site, you consent to the use of cookies.
OK
IPADMIN
: Study Drug Administration
Show annotations
Question
Response
Dosing Date
Dosing Time
Quantity Administered
Quantity Units
mL
Concentration of preparation
250 ug/mL
500 ug/mL
Reason for dose adjustment
Adverse Event
CRFs
Form List
Adverse Events
Device related physical activity and stress
Falls
Anti-hyperglycemic agents
General Concomitant Medications
Concomitant Medications
Consent Withdrawls
blood glucose reading as a custom domain
Nutrional Status
MUGA or Echocardiogram
Drug Accountability
Death
Demographics
Screen Fail Status
Electrocardiogram
Eligibility Criteria
Enrollment
End of Treatment
End of Study
EQ-5D-3L
EQ-5D-5L
Exposure-Infusion
Hepatobiliary assessment form
Injection Site Reaction
Hospitalizations
Study Drug Administration
Bone Marrow Aspirate
Laboratory Chemistry
Lab Coagulation
Laboratory Hematology
Pregnancy Test
Lab Urinalysis
General Medical History
Diabetes History
Diabetes Complications
General Medical History
Anemia History
Chronic Kidney Diseaase History
Mixed Meal Tolerance Test
Mini-Mental State Examination Summary
New Lesion
Non-target Lesion
Ophthamological Assessment
PK: Blood Sample Collection
Physical Examination
Physical Measurements
ECOG Performacne Status
Health Assessment Questionnaire - Disability Index
Blood Gases Assessment
SF 36 Health Survey
Subject Characteristics
Subject Identification
Substance Use
Target Lesion
Transfusions
Investigator Tumor Response Assessment
Visit Identification
Vital Signs
Work Productivity and Activity Impairment: Anemic Symptoms